Diagnostic and Prognostic Value of Serum Leptin in Critically Ill Patients with Acute versus Acute-on-Chronic Liver Failure
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3390/biomedicines12061170
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2024
- Urheber
-
Hohlstein, Philipp
Salvarcioglu, Can
Pollmanns, Maike
Adams, Jule K.
Abu Jhaisha, Samira
Kabak, Elena
Eisert, Albrecht
Hamesch, Mohamad Karim
Weiskirchen, Ralf
Koch, Alexander
Wirtz, Theresa
- DOI
-
10.18154/RWTH-2024-07110
- URN
-
urn:nbn:de:101:1-2408030213124.262239255099
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hohlstein, Philipp
- Salvarcioglu, Can
- Pollmanns, Maike
- Adams, Jule K.
- Abu Jhaisha, Samira
- Kabak, Elena
- Eisert, Albrecht
- Hamesch, Mohamad Karim
- Weiskirchen, Ralf
- Koch, Alexander
- Wirtz, Theresa
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2024
Ähnliche Objekte (12)
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Relevance of serum leptin and leptin-receptor concentrations in critically ill patients
Cell therapy in liver fibrosis
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
CCNs and other extracellular matrix proteins: an introduction to the special issue
Established liver cell lines: are you sure to have the right ones?
Established Hepatic Stellate Cell Lines in Hepatology Research
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Relevance of serum leptin and leptin-receptor concentrations in critically ill patients
Cell therapy in liver fibrosis
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
CCNs and other extracellular matrix proteins: an introduction to the special issue
Established liver cell lines: are you sure to have the right ones?
Established Hepatic Stellate Cell Lines in Hepatology Research
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Relevance of serum leptin and leptin-receptor concentrations in critically ill patients
Cell therapy in liver fibrosis
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
CCNs and other extracellular matrix proteins: an introduction to the special issue
Established liver cell lines: are you sure to have the right ones?
Established Hepatic Stellate Cell Lines in Hepatology Research
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step